CONCLUSIONS: The observed associations between serum FXR levels and obesity-related metabolic parameters suggest that FXR may be involved in the metabolic dysregulation accompanying increased adiposity. This evidence concerns the gene NR1H4 and obesity due to melanocortin 4 receptor deficiency.